MPA Business Services
Resources
Written for the people who source, launch and buy medicines rather than for lawyers. Every fact is linked to the register or judgment it comes from.
News
What changed, and what it means for sourcing, launch timing and supply. Dated, and updated when the position moves.
Case notes
Recent patent, SPC and parallel-trade decisions in the UK and Europe, each summarised plainly with the practical reading for traders, launch planners and buyers.
Regulatory changes
New rules that move exclusivity dates: the EU pharmaceutical package, UK divergence, SPC reform.
Watch list
Pending decisions and expiries worth tracking this quarter, with the dates to put in the diary.
Coming soon
Guides
How the rules and the records work. Evergreen, sourced to the registers, reviewed every year.
Explainers
SPCs, paediatric extensions, data exclusivity, licences and the other clocks that decide when a product opens up.
Country guides
Where the official patent, SPC, licensing and price data lives in each of 32 countries, and how to read it.
Coming soon
Prices
How medicine list prices are published across Europe, and what each published price actually is.
Product notes
The exclusivity position of widely traded products, country by country, as the registers state it.
Coming soon
Glossary
Patent, SPC, licensing and pricing terms, defined.
- What the fields in a patent or SPC record mean: priority, filing, publication, grant, designated states, status and the dates that matter
- The numbers on a patent document: INID codes explained
- Country codes and the registers behind them: the 32 countries, their abbreviations, patent offices, medicines agencies and currencies